Skip to main content
2025 CRT Conference Main banner

CRT 2025

Technology and Innovation

BRS DES and DCB Technologies

Panel Discussion | Will DCB Play a Role for Coronary Application in the US?

Monday, March 10, 2025
10:56 AM - 11:11 AM ET

    Panel Moderator(s)

  • Alexandre A. Abizaid, MD, PhD

    Director of Invasive Cardiology
    Incor
    SÃO PAULO, Sao Paulo, Brazil

    No relationships to disclose

  • Robert A. Byrne, MD, BCh, PhD

    Director of Cardiology
    Mater Private Hospital, RCSI University of Medicine and Health Sciences, Dublin, Ireland
    Dublin, Ireland

    No relationships to disclose

  • Florim Cuculi, MD

    Head of Cardiology
    Heart Center Lucerne, Luzern, Switzerland

    No relationships to disclose

    • Panel Discussant(s)

  • Bimmer Claessen, MD

    Interventional cardiologist
    Amsterdam University Medical Center

    No relationships to disclose

  • Antonio Colombo, MD

    Professor of Cardiology
    Humanitas IRCCS
    Milan, Lombardia, Italy

    No relationships to disclose

  • Manish Doshi, PhD

    Founder and Managing Director
    Concept Medical, Florida, United States

    No relationships to disclose

  • Jeffrey B. Jump, MSc

    Chairman and CEO
    MedAlliance
    Nyon, Vaud, Switzerland

    No relationships to disclose

  • Semih Oktay, PhD

    President
    Cardiomed Device Consultants
    Annapolis, Maryland, United States

    No relationships to disclose

  • Hany Ragy, MD

    Director of Cath lab
    hayat hospital Cairo
    cairo, Egypt

    No relationships to disclose

  • Patrick W. Serruys, MD, PhD

    Professor of Medical Intervention & Innovation
    University of Galway, Ireland

    Disclosure information not submitted.

Disclosure(s):
Alexandre A. Abizaid, MD, PhD: No financial relationships to disclose
Robert A. Byrne, MD, BCh, PhD: No financial relationships to disclose
Florim Cuculi, MD: No financial relationships to disclose
Marianne Brodmann, MD: No financial relationships to disclose
Bimmer Claessen, MD: Amgen: Consulting Fees (e.g., advisory boards) (Terminated); BBraun, Philips, Infraredx, Novo Nordisk: Grant/Research Support (Ongoing); Sanofi, Philips, BBraun, Abiomed, Abbott Vascular, Boston Scientific: Consulting Fees (e.g., advisory boards) (Terminated)
Antonio Colombo, MD: No financial relationships to disclose
Manish Doshi, PhD: Concept Medical: Employee (Ongoing), Stock-privately held company (Ongoing)
Jeffrey B. Jump, MSc: Transmural Systems, Inc.: Chairman (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Semih Oktay, PhD: I am a regulatory consultant to many cardiovascular device manufacturers: Consultant (Ongoing)
Hany Ragy, MD: No financial relationships to disclose
Patrick W. Serruys, MD, PhD: Merillife Sciences: Consulting Fees (e.g., advisory boards) (Ongoing)
Luca Testa, MD, PhD, Professor of Cardiology: No financial relationships to disclose